| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 8 3141-3147, Copyright © 1993 by American Association of Immunologists
ARTICLES |
KH Grabstein, CR Maliszewski, K Shanebeck, TA Sato, MK Spriggs, WC Fanslow and RJ Armitage
Department of Immunology, Immunex Research and Development Corporation, Seattle, WA 98101.
Our study demonstrates the central role for the murine CD40 ligand and IL-2 in contact-dependent T cell help for Ag-specific primary antibody responses in vitro. Helper T cell clones were found to express CD40 ligand after activation with CD3 mAb. Membrane-bound recombinant CD40 ligand expressed on fixed CV1/EBNA cells had similar B cell-activating properties as T cell clones that had been activated and then fixed. These activities include the induction of B cell proliferation, induction of polyclonal secretion of multiple Ig isotypes in a cytokine- dependent manner, and induction of Ag-specific antibody responses by purified B cells. The induction of polyclonal Ig secretion by the recombinant CD40 ligand required IL-4 and IL-5 although optimal Ag- specific antibody formation required IL-2. Finally, soluble CD40.Fc inhibited the induction of Ag-specific antibody responses by fixed, activated Th cell clones. The requirement for both CD40 ligand and IL-2 for induction of Ag-specific antibody responses was mediated, in part, by the induction of B cell IL-2R expression by CD40 ligand. We conclude that the interaction of CD40 on B cells with its ligand on activated T cells is an integral event in the early activation of B cells to grow and differentiate to antibody formation.
This article has been cited by other articles:
|
|
 |
|
  Y. Ohkubo, M. Arima, E. Arguni, S. Okada, K. Yamashita, S. Asari, S. Obata, A. Sakamoto, M. Hatano, J. O-Wang, et al. A Role for c-fos/Activator Protein 1 in B Lymphocyte Terminal Differentiation J. Immunol., June 15, 2005; 174(12): 7703 - 7710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Jelley-Gibbs, J. P. Dibble, S. Filipson, L. Haynes, R. A. Kemp, and S. L. Swain Repeated stimulation of CD4 effector T cells can limit their protective function J. Exp. Med., April 4, 2005; 201(7): 1101 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Nathan, J. E. Mold, S. C. Wood, K. Csencsits, G. Lu, E. J. Eichwald, and D. K. Bishop Requirement for Donor and Recipient CD40 Expression in Cardiac Allograft Rejection: Induction of Th1 Responses and Influence of Donor-Derived Dendritic Cells J. Immunol., June 1, 2004; 172(11): 6626 - 6633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. O. Lee, J. Moyron-Quiroz, J. Rangel-Moreno, K. L. Kusser, L. Hartson, F. Sprague, F. E. Lund, and T. D. Randall CD40, but Not CD154, Expression on B Cells Is Necessary for Optimal Primary B Cell Responses J. Immunol., December 1, 2003; 171(11): 5707 - 5717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. O. Lee, L. Haynes, S. M. Eaton, S. L. Swain, and T. D. Randall The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand Expression: Reciprocal Regulation by Interleukin (IL)-4 and IL-12 J. Exp. Med., September 2, 2002; 196(5): 693 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nierkens, P. van Helden, M. Bol, R. Bleumink, P. van Kooten, S. Ramdien-Murli, L. Boon, and R. Pieters Selective Requirement for CD40-CD154 in Drug-Induced Type 1 Versus Type 2 Responses to Trinitrophenyl-Ovalbumin J. Immunol., April 15, 2002; 168(8): 3747 - 3754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. He, C. M. Weyand, J. J. Goronzy, W. Zhong, and J. M. Stuart Bi-directional modulation of T cell-dependent antibody production by prostaglandin E2 Int. Immunol., January 1, 2002; 14(1): 69 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Williams, J. T. Tan, A. B. Adams, M. M. Durham, N. Shirasugi, J. K. Whitmire, L. E. Harrington, R. Ahmed, T. C. Pearson, and C. P. Larsen Characterization of Virus-Mediated Inhibition of Mixed Chimerism and Allospecific Tolerance J. Immunol., November 1, 2001; 167(9): 4987 - 4995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Erickson, T. M. Foy, and T. J. Waldschmidt Murine B1 B Cells Require IL-5 for Optimal T Cell-Dependent Activation J. Immunol., February 1, 2001; 166(3): 1531 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Chen, N. Singh, F. E. Yull, D. Strayhorn, L. Van Kaer, and L. D. Kerr Lymphocytes Lacking I{kappa}B-{alpha} Develop Normally, But Have Selective Defects in Proliferation and Function J. Immunol., November 15, 2000; 165(10): 5418 - 5427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Angelin-Duclos, G. Cattoretti, K.-I Lin, and K. Calame Commitment of B Lymphocytes to a Plasma Cell Fate Is Associated with Blimp-1 Expression In Vivo J. Immunol., November 15, 2000; 165(10): 5462 - 5471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Moore, O. Belvedere, A. Orr, K. Pieri, D. W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, et al. BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator Science, July 9, 1999; 285(5425): 260 - 263. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. Constant B Lymphocytes as Antigen-Presenting Cells for CD4+ T Cell Priming In Vivo J. Immunol., May 15, 1999; 162(10): 5695 - 5703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Millar, M. Wleklinski-Lee, and S. J. Kahn The Surface Protein Superfamily of Trypanosoma cruzi Stimulates a Polarized Th1 Response That Becomes Anergic J. Immunol., May 15, 1999; 162(10): 6092 - 6099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Johnson-Leger, J. R. Christenson, M. Holman, and G. G. B. Klaus Evidence for a Critical Role for IL-2 in CD40-Mediated Activation of Naive B Cells by Primary CD4 T Cells J. Immunol., November 1, 1998; 161(9): 4618 - 4626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Caux, C. Massacrier, B. Vanbervliet, B. Dubois, I. Durand, M. Cella, A. Lanzavecchia, and J. Banchereau CD34+ Hematopoietic Progenitors From Human Cord Blood Differentiate Along Two Independent Dendritic Cell Pathways in Response to Granulocyte-Macrophage Colony-Stimulating Factor Plus Tumor Necrosis Factor alpha : II. Functional Analysis Blood, August 15, 1997; 90(4): 1458 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Kwon, K. B. Tan, J. Ni, K. K. Kim, Y.-J. Kim, S. Wang, R. Gentz, G.-L. Yu, J. Harrop, S. D. Lyn, et al. A Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily with a Wide Tissue Distribution and Involvement in Lymphocyte Activation J. Biol. Chem., May 30, 1997; 272(22): 14272 - 14276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Dubois, B. Vanbervliet, J. Fayette, C. Massacrier, C. V. Kooten, F. Briere, J. Banchereau, and C. Caux Dendritic Cells Enhance Growth and Differentiation of CD40-activated B Lymphocytes J. Exp. Med., March 3, 1997; 185(5): 941 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Kubota and K Nakazato The role of duplication of tumour-derived chromosome 15 carrying the rearranged pvt-1 gene in the transformed phenotype of YACUT T-cell lymphoma x G4 T-cell line somatic cell hybrids in dictating the terminal differentiation program of the parental G4 cell J. Cell Sci., January 10, 1994; 107(10): 2761 - 2768. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
